SynthesisAmerican heart journal2017

New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.

Daniel J Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.